Genetic prediction models are poised to revolutionize medicine. But because they have been trained on European DNA, they threaten to widen health care disparities.
Fertility specialists, biotech companies and ethicists are divided over whether progress in early gene editing would wipe out diseases or trigger a rush toward enhancement.
As predictive medicine advances, legal scholars warn that decades-old federal guidelines could set up a potential clash between your genes and your job.